InvestorsHub Logo
Followers 12
Posts 1289
Boards Moderated 0
Alias Born 03/12/2020

Re: None

Monday, 03/15/2021 12:50:06 PM

Monday, March 15, 2021 12:50:06 PM

Post# of 933
Quietly gaining strength. News on progress of entering phase 1 trials should not be far away. Lots of confidence in Baum and Piazza. At right time this will make for a nice acquisition target imo, as company works on developing and gaining FDA approval of cancer drug CycloSam, 40x less toxic than counterpart FDA approved drug Quadramet.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent QSAM News